| Product Code: ETC13372914 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Short Bowel Syndrome Market was valued at USD 1.1 Billion in 2024 and is expected to reach USD 1.7 Billion by 2031, growing at a compound annual growth rate of 5.90% during the forecast period (2025-2031).
The Global Short Bowel Syndrome (SBS) market is experiencing significant growth due to the rising prevalence of the condition, which is often caused by surgical removal of a large portion of the small intestine. The market is characterized by a range of treatment options, including parenteral nutrition, enteral nutrition, and surgical interventions, as well as emerging therapies such as growth factors and new drug formulations. Key players in the market are investing in research and development to introduce innovative therapies and improve patient outcomes. The market is also driven by increasing awareness among healthcare professionals and patients, as well as favorable reimbursement policies in developed economies. Overall, the Global SBS market is poised for steady growth in the coming years as advancements in treatment options continue to address the unmet needs of patients with this rare and challenging condition.
The Global Short Bowel Syndrome (SBS) Market is witnessing significant growth due to the increasing prevalence of SBS, advancements in treatment options such as novel drug therapies and parenteral nutrition, and a rising focus on improving patient outcomes. The market is also benefiting from collaborations between pharmaceutical companies and research institutions to develop innovative therapies for SBS. Additionally, the increasing awareness about SBS among healthcare professionals and patients is driving market growth. Opportunities in the market include the development of personalized treatment approaches, expansion into emerging markets with unmet medical needs, and the potential for new product launches to address the evolving needs of SBS patients. Overall, the Global SBS Market is poised for expansion with a focus on improving patient quality of life and increasing treatment options.
The Global Short Bowel Syndrome Market faces several challenges, including limited awareness among healthcare professionals and patients, high treatment costs, and the lack of effective therapies. Short Bowel Syndrome is a rare and complex condition that requires specialized care, leading to difficulties in diagnosis and management. Additionally, the small patient population makes it challenging for pharmaceutical companies to invest in research and development of new treatments. Regulatory hurdles and reimbursement issues further hinder market growth. Addressing these challenges requires increased education and awareness initiatives, innovative treatment options, and collaboration among stakeholders to improve outcomes for patients with Short Bowel Syndrome.
The global Short Bowel Syndrome (SBS) market is primarily driven by the increasing prevalence of gastrointestinal disorders and related surgeries, which can lead to SBS. Additionally, the rising awareness about SBS among healthcare professionals and patients, coupled with advancements in medical technology and treatment options, are driving market growth. The growing focus on research and development activities to introduce innovative therapies and drugs for SBS management is also a significant driver. Furthermore, favorable government initiatives and healthcare policies aimed at improving patient outcomes and quality of life are contributing to the expansion of the global SBS market. Overall, the increasing incidence of SBS, combined with the efforts to enhance treatment options and patient care, are key drivers shaping the market landscape.
Government policies related to the Global Short Bowel Syndrome Market primarily focus on ensuring access to treatment options and support for patients with this rare disease. This includes regulatory initiatives to expedite the approval process for innovative therapies, as well as measures to incentivize research and development in the field. Additionally, governments may offer financial assistance or reimbursement programs to help offset the high costs associated with managing Short Bowel Syndrome, such as specialized medications and nutritional support. Policies also aim to improve awareness and education about the condition among healthcare providers and the general public, in order to facilitate early diagnosis and appropriate management strategies. Overall, government policies play a crucial role in shaping the landscape of the Global Short Bowel Syndrome Market by promoting patient access to effective treatments and fostering innovation in healthcare.
The Global Short Bowel Syndrome market is expected to witness significant growth in the coming years due to the increasing prevalence of the condition, advancements in medical technology, and a growing focus on novel treatment options. Factors such as the rising incidence of gastrointestinal diseases, improved diagnosis rates, and a shift towards personalized medicine are driving the market expansion. Additionally, the development of innovative therapies, including stem cell therapies, tissue engineering, and gene therapy, is expected to further boost market growth. With a rising demand for effective treatments and a favorable regulatory landscape supporting research and development activities, the Global Short Bowel Syndrome market is poised for substantial growth in the foreseeable future. Players in the market are likely to focus on strategic collaborations, product launches, and geographic expansion to capitalize on emerging opportunities and address unmet patient needs.
In the Global Short Bowel Syndrome market, Asia is expected to witness significant growth due to the increasing awareness about the disease and improving healthcare infrastructure. North America holds a prominent position with a high prevalence of the condition and a strong focus on research and development. Europe is also a key market with a growing patient population and favorable reimbursement policies. The Middle East and Africa region is anticipated to experience steady growth driven by improving access to healthcare services. Latin America is expected to show promising growth opportunities with rising investments in healthcare and increasing awareness about rare diseases like Short Bowel Syndrome. Overall, the market is poised for growth across all regions, driven by advancements in treatment options and increasing healthcare expenditure.
Global Short Bowel Syndrome Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Short Bowel Syndrome Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Short Bowel Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Global Short Bowel Syndrome Market - Industry Life Cycle |
3.4 Global Short Bowel Syndrome Market - Porter's Five Forces |
3.5 Global Short Bowel Syndrome Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Short Bowel Syndrome Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Global Short Bowel Syndrome Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Global Short Bowel Syndrome Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Global Short Bowel Syndrome Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Global Short Bowel Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Short Bowel Syndrome Market Trends |
6 Global Short Bowel Syndrome Market, 2021 - 2031 |
6.1 Global Short Bowel Syndrome Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Short Bowel Syndrome Market, Revenues & Volume, By Parenteral Nutrition, 2021 - 2031 |
6.1.3 Global Short Bowel Syndrome Market, Revenues & Volume, By Enteral Nutrition, 2021 - 2031 |
6.1.4 Global Short Bowel Syndrome Market, Revenues & Volume, By Pharmacological, 2021 - 2031 |
6.1.5 Global Short Bowel Syndrome Market, Revenues & Volume, By Surgical, 2021 - 2031 |
6.1.6 Global Short Bowel Syndrome Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Short Bowel Syndrome Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Short Bowel Syndrome Market, Revenues & Volume, By GLP-2 Analog, 2021 - 2031 |
6.2.3 Global Short Bowel Syndrome Market, Revenues & Volume, By Growth Hormones, 2021 - 2031 |
6.2.4 Global Short Bowel Syndrome Market, Revenues & Volume, By Anti-Diarrheal, 2021 - 2031 |
6.2.5 Global Short Bowel Syndrome Market, Revenues & Volume, By Immunosuppressants, 2021 - 2031 |
6.3 Global Short Bowel Syndrome Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Short Bowel Syndrome Market, Revenues & Volume, By Malabsorption, 2021 - 2031 |
6.3.3 Global Short Bowel Syndrome Market, Revenues & Volume, By Intestinal Failure, 2021 - 2031 |
6.3.4 Global Short Bowel Syndrome Market, Revenues & Volume, By Nutritional Deficiency, 2021 - 2031 |
6.3.5 Global Short Bowel Syndrome Market, Revenues & Volume, By Chronic Conditions, 2021 - 2031 |
6.4 Global Short Bowel Syndrome Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Short Bowel Syndrome Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Short Bowel Syndrome Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 Global Short Bowel Syndrome Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4.5 Global Short Bowel Syndrome Market, Revenues & Volume, By Specialty Centers, 2021 - 2031 |
7 North America Short Bowel Syndrome Market, Overview & Analysis |
7.1 North America Short Bowel Syndrome Market Revenues & Volume, 2021 - 2031 |
7.2 North America Short Bowel Syndrome Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Short Bowel Syndrome Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4 North America Short Bowel Syndrome Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.5 North America Short Bowel Syndrome Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America Short Bowel Syndrome Market, Revenues & Volume, By End Use, 2021 - 2031 |
8 Latin America (LATAM) Short Bowel Syndrome Market, Overview & Analysis |
8.1 Latin America (LATAM) Short Bowel Syndrome Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Short Bowel Syndrome Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Short Bowel Syndrome Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
8.4 Latin America (LATAM) Short Bowel Syndrome Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
8.5 Latin America (LATAM) Short Bowel Syndrome Market, Revenues & Volume, By Application, 2021 - 2031 |
8.6 Latin America (LATAM) Short Bowel Syndrome Market, Revenues & Volume, By End Use, 2021 - 2031 |
9 Asia Short Bowel Syndrome Market, Overview & Analysis |
9.1 Asia Short Bowel Syndrome Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Short Bowel Syndrome Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Short Bowel Syndrome Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
9.4 Asia Short Bowel Syndrome Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
9.5 Asia Short Bowel Syndrome Market, Revenues & Volume, By Application, 2021 - 2031 |
9.6 Asia Short Bowel Syndrome Market, Revenues & Volume, By End Use, 2021 - 2031 |
10 Africa Short Bowel Syndrome Market, Overview & Analysis |
10.1 Africa Short Bowel Syndrome Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Short Bowel Syndrome Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Short Bowel Syndrome Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
10.4 Africa Short Bowel Syndrome Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
10.5 Africa Short Bowel Syndrome Market, Revenues & Volume, By Application, 2021 - 2031 |
10.6 Africa Short Bowel Syndrome Market, Revenues & Volume, By End Use, 2021 - 2031 |
11 Europe Short Bowel Syndrome Market, Overview & Analysis |
11.1 Europe Short Bowel Syndrome Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Short Bowel Syndrome Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Short Bowel Syndrome Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
11.4 Europe Short Bowel Syndrome Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
11.5 Europe Short Bowel Syndrome Market, Revenues & Volume, By Application, 2021 - 2031 |
11.6 Europe Short Bowel Syndrome Market, Revenues & Volume, By End Use, 2021 - 2031 |
12 Middle East Short Bowel Syndrome Market, Overview & Analysis |
12.1 Middle East Short Bowel Syndrome Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Short Bowel Syndrome Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Short Bowel Syndrome Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Short Bowel Syndrome Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
12.4 Middle East Short Bowel Syndrome Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
12.5 Middle East Short Bowel Syndrome Market, Revenues & Volume, By Application, 2021 - 2031 |
12.6 Middle East Short Bowel Syndrome Market, Revenues & Volume, By End Use, 2021 - 2031 |
13 Global Short Bowel Syndrome Market Key Performance Indicators |
14 Global Short Bowel Syndrome Market - Export/Import By Countries Assessment |
15 Global Short Bowel Syndrome Market - Opportunity Assessment |
15.1 Global Short Bowel Syndrome Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Short Bowel Syndrome Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
15.3 Global Short Bowel Syndrome Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
15.4 Global Short Bowel Syndrome Market Opportunity Assessment, By Application, 2021 & 2031F |
15.5 Global Short Bowel Syndrome Market Opportunity Assessment, By End Use, 2021 & 2031F |
16 Global Short Bowel Syndrome Market - Competitive Landscape |
16.1 Global Short Bowel Syndrome Market Revenue Share, By Companies, 2024 |
16.2 Global Short Bowel Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here